Vela Diagnostics announced a collaboration with the National Cancer Centre of Singapore (NCCS) to develop a molecular diagnostic…
Year: 2021
The Vie Co. Announces Grand Opening in Cryotherapy Innovation in Los Angeles
The Vie Co. officially announced the grand opening of their newest state of the art cryotherapy spa…
Alkermes to Take Part in the Goldman Sachs Annual Global Healthcare Conference
Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at the Goldman…
Helix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral Surveillance
Helix, the leading population genomics and COVID-19 testing company, has closed on its Series C funding…
Qazi Cosmetic Clinic Announces Pain-Free MicroLipo™ to Banish Double Chins and Saggy Skin Just in Time for the End of the Pandemic
Spending the past year on Zoom, with its magical retouching and soft-light camera features, has been…
Lung Cancer Research Foundation and EGFR Resisters Announce Partnership
The Lung Cancer Research Foundation (LCRF) is excited to announce a partnership with leading lung cancer…
Choice Health at Home Announces Multiple Acquisitions in Texas and Oklahoma
Choice Health at Home, LLC (“Choice”) announced today the acquisition of multiple home health and hospice…
Cantel Medical LLC Announces Offer to Purchase Relating to Outstanding Convertible Senior Notes
Cantel Medical LLC, formerly known as Cantel Medical Corp. (the “Company,” “Cantel,” “we” or “our”), today…
FieldLine Launches HEDscan™, a Next-Generation Device for Non-Invasive Functional Brain Imaging
FieldLine Inc., a biotech company targeting advanced brain diagnostic technology, announced today the general availability of…
Bridge Biotherapeutics Announces the Initiation of the Proof of Mechanism Study for BBT-401 in Patients with Ulcerative Colitis
Bridge Biotherapeutics (KQ288330) today announced the first patient dosing of BBT-401 in its open label, proof…